je.st
news
Tag: clinical
J&J Ebola vaccine to start clinical trials in early 2015
2014-09-04 14:05:05| Biotech - Topix.net
Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson, in another sign that the world's worst outbreak of the virus is mobilising research into the deadly disease. J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic, would commence in early 2015.
Tags: start
early
clinical
trials
J&J Ebola vaccine to start clinical trials in early 2015
2014-09-04 12:21:08| Food - Topix.net
Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson, in another sign that the world's worst outbreak of the virus is mobilising research into the deadly disease. J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic, would commence in early 2015.
Tags: start
early
clinical
trials
ARCA Biopharma Announces Health Canada Acceptance Of Genetic-AF Clinical Trial Application
2014-09-03 11:53:10| drugdiscoveryonline Home Page
ARCA biopharma, Inc. a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, recently announced that the Company’s Clinical Trial Application (CTA) for the GENETIC-AF clinical trial evaluating GencaroTM as a potential treatment for atrial fibrillation (AF) has been accepted by Health Canada
Tags: health
canada
application
trial
La Jolla Pharmaceutical Company Announces First Patient Enrolled In Clinical Trial Of LJPC-501 In Hepatorenal Syndrome
2014-09-03 11:49:25| drugdiscoveryonline Home Page
La Jolla Pharmaceutical Company a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, recently announced that the first patient has been enrolled in the Phase 1/2 clinical trial of LJPC-501 for the treatment of type 1 and type 2 hepatorenal syndrome (HRS). HRS is a life-threatening form of progressive renal failure in patients with liver cirrhosis or fulminant liver failure
Tags: company
trial
patient
clinical
Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent FF-10501' For FUJIFILM In Patients With Advanced Hematologic Malignancies
2014-09-03 11:37:54| drugdiscoveryonline Home Page
Boston Strategics Corporation (BSC), a primary global strategic drug development provider for FUJIFILM Pharmaceuticals U.S.A., Inc. (FPHU), has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in the United States in patients with advanced hematologic malignancies, such as relapsed or refractory high-risk myelodysplastic syndromes (MDS)
Tags: with
advanced
corporation
agent
Sites : [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] next »